PL424963A1 - Crystalline form of the complex of dihydrate triaquabis(1,3-dimethylxanthine)copper(II) and method for producing it - Google Patents

Crystalline form of the complex of dihydrate triaquabis(1,3-dimethylxanthine)copper(II) and method for producing it

Info

Publication number
PL424963A1
PL424963A1 PL424963A PL42496318A PL424963A1 PL 424963 A1 PL424963 A1 PL 424963A1 PL 424963 A PL424963 A PL 424963A PL 42496318 A PL42496318 A PL 42496318A PL 424963 A1 PL424963 A1 PL 424963A1
Authority
PL
Poland
Prior art keywords
dimethylxanthine
copper
crystalline form
dihydrate
complex
Prior art date
Application number
PL424963A
Other languages
Polish (pl)
Other versions
PL239998B1 (en
Inventor
Agnieszka Wojciechowska
Jan Janczak
Original Assignee
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Wrocławska filed Critical Politechnika Wrocławska
Priority to PL424963A priority Critical patent/PL239998B1/en
Publication of PL424963A1 publication Critical patent/PL424963A1/en
Publication of PL239998B1 publication Critical patent/PL239998B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Zgłoszenie dotyczy krystalicznej formy kompleksu dihydrat triakwabis(1.3-dimetyloksantyno)miedź(II) o wzorze 1, znajdującej zastosowanie jako składnik leku o wolnym uwalnianiu i kontrolowanym stężeniu teofiliny. Zgłoszenie obejmuje również sposób wytwarzania krystalicznej formy kompleksu dihydrat triakwabis(1.3-dimetyloksantyno)miedź(II) o wzorze 1, który charakteryzuje się tym, że jedną część molową uwodnionej soli octanu miedzi(II), rozpuszcza się w wodzie i poddaje się reakcji z dwiema częściami molowymi wodnego roztworu 1.3-dimetyloksantyny z dodatkiem 80% stężonego kwasu octowego. Po minimum 14 dniach otrzymuje się krystaliczną formę dihydrat triakwabis(1.3-dimetyloksantyno)miedź(II) o wzorze 1.The application relates to the crystalline form of the triacquisbis (1.3-dimethylxanthine) copper (II) dihydrate complex of formula 1, which is used as a component of a slow release drug and a controlled concentration of theophylline. The application also includes a process for producing the crystalline form of the triacquisbis (1.3-dimethylxanthine) copper (II) dihydrate complex, which is characterized in that one molar part of the hydrated salt of copper (II) acetate is dissolved in water and reacted with two mole parts of aqueous 1.3-dimethylxanthine with 80% concentrated acetic acid. After a minimum of 14 days, the crystalline form triacquisbis (1.3-dimethylxanthine) copper (II) dihydrate is obtained with formula (1).

PL424963A 2018-03-21 2018-03-21 Crystalline form of the complex of dihydrate triaquabis(1,3-dimethylxanthine)copper(II) and method for producing it PL239998B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL424963A PL239998B1 (en) 2018-03-21 2018-03-21 Crystalline form of the complex of dihydrate triaquabis(1,3-dimethylxanthine)copper(II) and method for producing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL424963A PL239998B1 (en) 2018-03-21 2018-03-21 Crystalline form of the complex of dihydrate triaquabis(1,3-dimethylxanthine)copper(II) and method for producing it

Publications (2)

Publication Number Publication Date
PL424963A1 true PL424963A1 (en) 2018-11-05
PL239998B1 PL239998B1 (en) 2022-02-07

Family

ID=63998350

Family Applications (1)

Application Number Title Priority Date Filing Date
PL424963A PL239998B1 (en) 2018-03-21 2018-03-21 Crystalline form of the complex of dihydrate triaquabis(1,3-dimethylxanthine)copper(II) and method for producing it

Country Status (1)

Country Link
PL (1) PL239998B1 (en)

Also Published As

Publication number Publication date
PL239998B1 (en) 2022-02-07

Similar Documents

Publication Publication Date Title
MX2020005956A (en) Organic sulfonic acid salts of amino acid esters and process for their preparation.
EA201991055A1 (en) METHOD FOR PRODUCING PYRAZOLE [1,5-a] PYRIMIDINES AND THEIR SALTS
MX2018001145A (en) Methods for preparation of bile acids and derivatives thereof.
DK1185520T3 (en) Process for the preparation of thiazolidine
ATE520649T1 (en) METHOD FOR PRODUCING LOW BY-PRODUCT METHYLGLYCINE-N,N-DIACETIC ACID TRIAL POTASSIUM METAL SALTS
MY197242A (en) Acid addition salts of benzimidazole derivative
NO20054100D0 (en) Process for the preparation of acid addition salts
CY1123317T1 (en) METHOD FOR PRODUCING CRYSTALLINE FORM OF MODIFICATION A OF CALCOBUTROL
PH12016501175A1 (en) Formulations of deoxycholic acid and salts thereof
PL424963A1 (en) Crystalline form of the complex of dihydrate triaquabis(1,3-dimethylxanthine)copper(II) and method for producing it
EA201390825A1 (en) PRELIMINARY DILUTION (PREPARATION) OF THE FLOCULATOR FOR FILTERING A GYPSUM WHEN RECEIVING A PHOSPHORIC ACID AND SUBSEQUENT FILTERING OF PHOSPHORIC ACID
PL420099A1 (en) Method for production of alpha-ketoglutaric acid (AKG) from one-component water solutions
PL431708A1 (en) Crystalline form of bis(L-arginine)di(thiocyanate)copper(II) hydrate 1/2 complex and method of its preparation
PL431213A1 (en) Crystalline form of bis(L-arginine)copper(II)diazide hydrate 1/3 complex and its production method
PL431215A1 (en) Crystalline form of azide bis(L-arginine)chlorine-copper(Il)bis(L-arginine)diazido-copper(II) hydrate 1/7 complex and method of its production
PH12018501046A1 (en) Crystals of monovalent cation salt of 3-hydroxyisovaleric acid, and method for producing said crystals
PL431214A1 (en) Crystalline form of catena {(L-arginine)(�-azido-N,N')azido-copper(II)} complex and method of its production
PL410425A1 (en) New alkoxymethyl di(2-hydroxyethyl)methylammonium ionic liquids with sweet anion and method for producing them
PL431212A1 (en) Crystalline form of diaquabis(L-arginine)copper(II) azide complex and method of its preparation
PL433218A1 (en) Crystalline form of the complex bis (L-arginine) azide copper (II) bis (L-arginine) diazide copper (II) hydrate 1/6 and its preparation
PL417574A1 (en) Crystalline form of the complex of nitrate(V) aqua((2S)-2-amino-3-(4-hydroxy-3,5-diiodo phenyl)-propane)(1,10-phenanthroline) copper(II) and method for producing it
PL417572A1 (en) Crystalline form of the complex of dihydrate ((2S)-2-amino-3-(4-hydroxy-3,5-diiodo phenyl)-propane)chloro(1,10-phenanthroline) copper(II) and method for producing it
TH1801002888A (en) Monovalent Crystals of Salt 3- hydroxy isovalic acid And processes for producing crystals
RU2013120795A (en) METHOD FOR PRODUCING 3 ', 5'-DIODIOPHOLIC ACID
PL439911A1 (en) Crystalline form of the coordination polymer poly-bis(L-arginine)octaazidetetracopper(II) hydrate and method of its preparation